// App-Quantinova.ai

AB0257 (2021) : IMPACT OF CONVENTIONAL ANTIRHEUMATIC TREATMENT ON CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS

Researchers

Presenter

  • D. Gerasimova

Principal Investigators

  • E. Gerasimova

  • T. Popkova

Medical Centers

  • I.M. Sechenov First Moscow State Medical University (Sechenov University), Department of Organization and Economy of Pharmacy, Moscow, Russian Federation

  • V.A. Nasonova Research Institute of Rheumatology, Vascular Disease Laboratory, Moscow, Russian Federation

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Sulfasalazine

  • Methotrexate

  • leflunomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved